Mycophenolate Mofetil for Eosinophilic Fasciitis: A Retrospective Analysis From 3 Tertiary Care Centers

JAMA Dermatol. 2020 May 1;156(5):595-597. doi: 10.1001/jamadermatol.2020.0120.

Authors

Elizabeth Tkachenko^{1

2}, Alexa B Steuer³, Kelly Lo², Avery LaChance², Joseph F Merola², Alisa N Femia³, Ruth Ann Vleugels²

Affiliations

¹ University of Massachusetts Medical School, Worcester, Massachusetts.
² Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts.
³ The Ronald O. Perelman Department of Dermatology, New York University Langone Medical Center, New York.

Abstract

This cohort study examines the clinical response outcomes of 14 patients with eosinophilic fasciitis treated with mycophenolate mofetil.

Publication types

Multicenter Study

MeSH terms

Eosinophilia / drug therapy*
Fasciitis / drug therapy*
Female
Humans
Immunosuppressive Agents / administration & dosage*
Male
Mycophenolic Acid / administration & dosage*
Retrospective Studies
Tertiary Care Centers
Treatment Outcome

Substances

Immunosuppressive Agents
Mycophenolic Acid

Supplementary concepts

Eosinophilic Fasciitis